Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 January 2020, London - Main contents
date | January 13, 2020 - January 16, 2020 |
---|---|
city | London, Great Britain |
organisation | European Medicines Agency (EMA) i |
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
The EMA is responsible for the scientific evaluation of applications for European marketing authorisation for medicinal products (centralised procedure). Under the centralised procedure, companies submit one single marketing authorisation application to the EMA.